Pharmaceuticals 2011, 4(1), 1-6; doi:10.3390/ph4010001
Review

Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs

Received: 20 December 2010; Accepted: 22 December 2010 / Published: 23 December 2010
(This article belongs to the Special Issue Antihypertensive Drugs)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Several studies have shown that blood pressure can be lowered by the use of drugs that are not traditional antihypertensive drugs. This might be of clinical importance when many risk patients are treated by combination drug therapy in order to prevent cardiovascular disease by way of improving the cardiovascular risk factor profile.
Keywords: blood pressure; glitazone; metformin; orlistat; rimonabant; sibutramine; sitagliptin; statin
PDF Full-text Download PDF Full-Text [36 KB, uploaded 23 December 2010 10:36 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Nilsson, P.M.; Cifkova, R. Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs. Pharmaceuticals 2011, 4, 1-6.

AMA Style

Nilsson PM, Cifkova R. Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs. Pharmaceuticals. 2011; 4(1):1-6.

Chicago/Turabian Style

Nilsson, Peter M.; Cifkova, Renata. 2011. "Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs." Pharmaceuticals 4, no. 1: 1-6.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert